| Dr Thomas C Wolf, MD | |
|
3431 S Boulevard St, Suite 106, Edmond, OK 73013-5475 | |
| (405) 562-2036 | |
| (405) 562-2116 |
| Full Name | Dr Thomas C Wolf |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 44 Years |
| Location | 3431 S Boulevard St, Edmond, Oklahoma |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124088067 | NPI | - | NPPES |
| 100110830B | Medicaid | OK | |
| DA7066 | Other | OK | MEDICARE RAILROAD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 13218 (Oklahoma) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Dr Thomas Wolf And Associates Pllc | 3476440645 | 3 |
News Archive
Applied Nanoscience Inc. (ANI) (PINKSHEETS: APNN), a nanotechnology-based filtration development company, today announced it has reached a joint venture agreement to begin production on a disposable protective face mask with its Asia Pacific region partner. The protective mask will incorporate ANI's proprietary NanoFense™ technology, a U.S. patent pending antimicrobial nanoparticle formulation.
New findings from an in vitro study, led by researchers at Brigham and Women's Hospital (BWH), show that the combination of statins and eicosapentaenoic acid (EPA), an omega-3 fatty acid, may potentially reduce cardiovascular risk.
A new paper describes a strategy that could help decide which workers can safely go back to work once a lockdown is easing off. The study, published on the preprint server medRxiv* in May 2020, could help to apply required measures for serological testing and income replacement among affected workers with accuracy and completeness.
Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that although Amylin/Eli Lilly's Byetta currently commands a higher patient share than Novo Nordisk's Victoza, more patients were switched from Byetta to Victoza than vice versa (25.2 percent versus 2.8 percent) in the last quarter of 2010 among recently treated type 2 diabetes patients.
The United States Food and Drug Administration (FDA) have waged a war against smoking and now new steps are in place to help quitters go ahead and stop smoking.
› Verified 2 days ago
| Entity Name | Dr Thomas Wolf And Associates Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1992754949 PECOS PAC ID: 3476440645 Enrollment ID: O20040302000881 |
News Archive
Applied Nanoscience Inc. (ANI) (PINKSHEETS: APNN), a nanotechnology-based filtration development company, today announced it has reached a joint venture agreement to begin production on a disposable protective face mask with its Asia Pacific region partner. The protective mask will incorporate ANI's proprietary NanoFense™ technology, a U.S. patent pending antimicrobial nanoparticle formulation.
New findings from an in vitro study, led by researchers at Brigham and Women's Hospital (BWH), show that the combination of statins and eicosapentaenoic acid (EPA), an omega-3 fatty acid, may potentially reduce cardiovascular risk.
A new paper describes a strategy that could help decide which workers can safely go back to work once a lockdown is easing off. The study, published on the preprint server medRxiv* in May 2020, could help to apply required measures for serological testing and income replacement among affected workers with accuracy and completeness.
Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that although Amylin/Eli Lilly's Byetta currently commands a higher patient share than Novo Nordisk's Victoza, more patients were switched from Byetta to Victoza than vice versa (25.2 percent versus 2.8 percent) in the last quarter of 2010 among recently treated type 2 diabetes patients.
The United States Food and Drug Administration (FDA) have waged a war against smoking and now new steps are in place to help quitters go ahead and stop smoking.
› Verified 2 days ago
| Entity Name | Oklahoma Eye Care Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275693087 PECOS PAC ID: 8820089816 Enrollment ID: O20040519000846 |
News Archive
Applied Nanoscience Inc. (ANI) (PINKSHEETS: APNN), a nanotechnology-based filtration development company, today announced it has reached a joint venture agreement to begin production on a disposable protective face mask with its Asia Pacific region partner. The protective mask will incorporate ANI's proprietary NanoFense™ technology, a U.S. patent pending antimicrobial nanoparticle formulation.
New findings from an in vitro study, led by researchers at Brigham and Women's Hospital (BWH), show that the combination of statins and eicosapentaenoic acid (EPA), an omega-3 fatty acid, may potentially reduce cardiovascular risk.
A new paper describes a strategy that could help decide which workers can safely go back to work once a lockdown is easing off. The study, published on the preprint server medRxiv* in May 2020, could help to apply required measures for serological testing and income replacement among affected workers with accuracy and completeness.
Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that although Amylin/Eli Lilly's Byetta currently commands a higher patient share than Novo Nordisk's Victoza, more patients were switched from Byetta to Victoza than vice versa (25.2 percent versus 2.8 percent) in the last quarter of 2010 among recently treated type 2 diabetes patients.
The United States Food and Drug Administration (FDA) have waged a war against smoking and now new steps are in place to help quitters go ahead and stop smoking.
› Verified 2 days ago
| Entity Name | Eye Care Specialists Of Oklahoma Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427556166 PECOS PAC ID: 4789945239 Enrollment ID: O20180227000058 |
News Archive
Applied Nanoscience Inc. (ANI) (PINKSHEETS: APNN), a nanotechnology-based filtration development company, today announced it has reached a joint venture agreement to begin production on a disposable protective face mask with its Asia Pacific region partner. The protective mask will incorporate ANI's proprietary NanoFense™ technology, a U.S. patent pending antimicrobial nanoparticle formulation.
New findings from an in vitro study, led by researchers at Brigham and Women's Hospital (BWH), show that the combination of statins and eicosapentaenoic acid (EPA), an omega-3 fatty acid, may potentially reduce cardiovascular risk.
A new paper describes a strategy that could help decide which workers can safely go back to work once a lockdown is easing off. The study, published on the preprint server medRxiv* in May 2020, could help to apply required measures for serological testing and income replacement among affected workers with accuracy and completeness.
Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that although Amylin/Eli Lilly's Byetta currently commands a higher patient share than Novo Nordisk's Victoza, more patients were switched from Byetta to Victoza than vice versa (25.2 percent versus 2.8 percent) in the last quarter of 2010 among recently treated type 2 diabetes patients.
The United States Food and Drug Administration (FDA) have waged a war against smoking and now new steps are in place to help quitters go ahead and stop smoking.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Thomas C Wolf, MD 3431 S Boulevard St, Suite 106, Edmond, OK 73013-5475 Ph: (405) 562-2036 | Dr Thomas C Wolf, MD 3431 S Boulevard St, Suite 106, Edmond, OK 73013-5475 Ph: (405) 562-2036 |
News Archive
Applied Nanoscience Inc. (ANI) (PINKSHEETS: APNN), a nanotechnology-based filtration development company, today announced it has reached a joint venture agreement to begin production on a disposable protective face mask with its Asia Pacific region partner. The protective mask will incorporate ANI's proprietary NanoFense™ technology, a U.S. patent pending antimicrobial nanoparticle formulation.
New findings from an in vitro study, led by researchers at Brigham and Women's Hospital (BWH), show that the combination of statins and eicosapentaenoic acid (EPA), an omega-3 fatty acid, may potentially reduce cardiovascular risk.
A new paper describes a strategy that could help decide which workers can safely go back to work once a lockdown is easing off. The study, published on the preprint server medRxiv* in May 2020, could help to apply required measures for serological testing and income replacement among affected workers with accuracy and completeness.
Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that although Amylin/Eli Lilly's Byetta currently commands a higher patient share than Novo Nordisk's Victoza, more patients were switched from Byetta to Victoza than vice versa (25.2 percent versus 2.8 percent) in the last quarter of 2010 among recently treated type 2 diabetes patients.
The United States Food and Drug Administration (FDA) have waged a war against smoking and now new steps are in place to help quitters go ahead and stop smoking.
› Verified 2 days ago
Bradley Don Britton, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 14701 N Santa Fe Ave, Edmond, OK 73013 Phone: 405-752-2733 Fax: 405-752-2172 | |
Mrs. Laura Sarfatis Miles, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 912 Nw 139th Street Pkwy, Edmond, OK 73013 Phone: 405-608-4447 Fax: 405-286-1261 | |
Jeffrey T Shaver, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 3840 South Boulevard, Suite 101, Edmond, OK 73013 Phone: 405-471-5252 Fax: 405-726-8530 | |
Brian Dale Morgan, M.D. Ophthalmology Medicare: May Accept Medicare Assignments Practice Location: 14701 N Santa Fe Ave, Edmond, OK 73013 Phone: 405-752-2733 Fax: 405-752-2172 | |
Robert D Gourley, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 920 S Bryant Ave, Ste 100, Edmond, OK 73034 Phone: 405-341-4238 Fax: 405-340-0269 | |
Dr. Sandeep N Shah, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1851 S Kelly Ave Ste A, Edmond, OK 73013 Phone: 405-607-6699 Fax: 405-607-6685 |